Aehr insider plans sale of 5,973 shares

Aehr Test Systems insider Rhea Posedel filed a notice to sell common stock under a Form 144.

Rhea-AI Filing Summary

Aehr Test Systems insider Rhea Posedel filed a notice to sell common stock under a Form 144. The planned sale covers 5,973 common shares through broker Oppenheimer & Co. Inc., with an aggregate market value of $836,220.00, expected on or about August 14, 2026 on Nasdaq.

The shares were originally acquired on April 20, 2021 as compensation from the issuer. Over the past three months, a separate sale of 8,413 common shares for an aggregate $1,093,690.00 was reported.

Key Figures

Shares proposed for sale: 5,973 shares Aggregate market value (proposed sale): $836,220.00 Prior 3-month shares sold: 8,413 shares +3 more

6 metrics

Shares proposed for sale 5,973 shares Common stock covered by the Form 144 notice

Aggregate market value (proposed sale) $836,220.00 Value of 5,973 common shares in proposed Form 144 sale

Prior 3-month shares sold 8,413 shares Common shares sold during the past three months

Aggregate value of prior sale $1,093,690.00 Aggregate amount for 8,413 common shares sold in past three months

Acquisition date of shares 04/20/2021 Date shares were acquired as compensation from the issuer

Approximate sale date 08/14/2026 Approximate date of proposed sale of 5,973 shares

Key Terms

Form 144, aggregate market value, compensation, Securities To Be Sold

4 terms

Form 144 regulatory

"filed a notice to sell common stock under a Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

aggregate market value financial

"with an aggregate market value of $836,220.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

compensation financial

"The shares were originally acquired on April 20, 2021 as compensation"

Securities To Be Sold regulatory

"144: Securities To Be Sold common | 04/20/2021 | compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AEHR’s Form 144 filing by Rhea Posedel disclose?

It discloses a planned sale of 5,973 AEHR common shares with an aggregate market value of $836,220.00, to be sold through Oppenheimer & Co. Inc. around August 14, 2026 on Nasdaq.

How many AEHR shares is Rhea Posedel planning to sell under this Form 144?

Rhea Posedel plans to sell 5,973 common shares of AEHR. These shares have an aggregate market value of $836,220.00 based on the information provided in the Form 144 notice of proposed sale.

When were the AEHR shares being sold by Rhea Posedel originally acquired?

The shares were acquired on April 20, 2021 as compensation from the issuer. This indicates the Form 144 relates to stock received in a compensation transaction rather than an open-market purchase.

Which broker is handling the proposed AEHR share sale for Rhea Posedel?

The proposed sale of AEHR shares will be handled by Oppenheimer & Co. Inc., located at 85 Broad St, New York, NY 10004. The filing also notes trading on Nasdaq as the intended exchange.

What AEHR stock sales has Rhea Posedel reported in the past three months?

The filing lists a prior sale of 8,413 common shares of AEHR during the past three months for an aggregate amount of $1,093,690.00. This is separate from the newly proposed 5,973-share sale.

What is the aggregate market value of AEHR shares in Rhea Posedel’s proposed Form 144 sale?

The proposed sale covers shares with an aggregate market value of $836,220.00. This value corresponds to the 5,973 common shares identified in the Form 144 filing for potential sale on Nasdaq.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 03:41 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001055117
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AEHR TEST SYSTEMS
SEC File Number	000-22893
Address of Issuer	400 KATO TERRACE FREMONT CALIFORNIA 94539
Phone	5106239400
Name of Person for Whose Account the Securities are To Be Sold	POSEDEL RHEA J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Oppenheimer & Co, Inc 85 Broad St New York NY 10004	5973	836220.00	32620450	08/14/2026	nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	04/20/2021	compensation	issuer			5973	04/20/2021	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Rhea Posedel 400 Kato Terrace Fremont CA 94539	common	08/12/2026	8413	1093690.00

144: Remarks and Signature

Remarks	POA on file, 8/14/26
Date of Notice	08/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rhea Posedel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)